Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astria Therapeutics (ATXS) Change in Accured Expenses: 2017-2019

Historic Change in Accured Expenses for Astria Therapeutics (ATXS) over the last 3 years, with Dec 2019 value amounting to $82,000.

  • Astria Therapeutics' Change in Accured Expenses fell 36.43% to $82,000 in Q4 2019 from the same period last year, while for Dec 2019 it was -$205,000, marking a year-over-year decrease of 151.77%. This contributed to the annual value of $3.7 million for FY2024, which is 84.29% up from last year.
  • As of Q4 2019, Astria Therapeutics' Change in Accured Expenses stood at $82,000, which was up 364.52% from -$31,000 recorded in Q3 2019.
  • In the past 5 years, Astria Therapeutics' Change in Accured Expenses registered a high of $1.1 million during Q2 2019, and its lowest value of -$1.3 million during Q1 2019.
  • Over the past 3 years, Astria Therapeutics' median Change in Accured Expenses value was -$154,000 (recorded in 2018), while the average stood at -$85,333.
  • The largest annual percentage gain for Astria Therapeutics' Change in Accured Expenses in the last 5 years was 265.46% (2018), contrasted with its biggest fall of 671.43% (2018).
  • Over the past 3 years, Astria Therapeutics' Change in Accured Expenses (Quarterly) stood at -$312,000 in 2017, then spiked by 141.35% to $129,000 in 2018, then tumbled by 36.43% to $82,000 in 2019.
  • Its Change in Accured Expenses stands at $82,000 for Q4 2019, versus -$31,000 for Q3 2019 and $1.1 million for Q2 2019.